Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
Designing More Representative Trials Through Strategic Planning
Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.
Five Predictions For Clinical Research In 2025
In 2025, AI-powered adaptive protocols will redefine study design, shifting the industry from rigid, pre-planned models to flexible, real-world-optimized trials.
The Growing Complexity Of Conducting Oncology Trials
As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.

ADCs In Oncology Trials Webinar
10/2/2025

Whether you are preparing to launch your first ADC study or looking to optimize current programs, this session will deliver practical insights you can put into action immediately.
Challenges To Making Go/No-Go Decisions In Clinical Trials
7/16/2026

In drug development, a go/no-go decision can be a high-stakes trade-off between speed and certainty. Delve into the real-world operational and strategic hurdles to making those decisions.
Stop Treating Patient Samples As Acceptable Losses
7/17/2026

This short webinar excerpt pushes back on the idea that preventable biological sample loss should be tolerated as a routine part of trial execution.
Use Data For Fit-For-Purpose Patient Recruitment Strategy
10/29/2025

Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.
Executing Concurrent Decentralized RCTs And RWE At Scale
3/31/2026

See how a team of four managed data for 40 peer-reviewed studies and 200,000 participants.

Overcome Biosafety Challenges With An Innovative IBC

Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility

Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
Visit Management Solution Built For Global Trials

From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.
Making The Impossible Possible In Oncology And Hematology Clinical Development

When the complexities of designing and executing cancer trials in a highly competitive market can mean delays in delivering urgently needed treatments to patients, it pays to have a trusted partner by your side.
Optimize And Expedite Clinical Trial Design, Planning, and Execution

Obtain smarter, faster, and more resilient clinical trials that reduce cost, improve outcomes, and bring life-changing therapies to patients sooner with integrated, user-friendly technology.